Passage of vasoactive intestinal peptide across the blood-brain barrier

被引:56
|
作者
Dogrukol-Ak, D [1 ]
Banks, WA
Tuncel, N
Tuncel, M
机构
[1] Anadolu Univ, Fac Pharm, Dept Analyt Chem, TR-26470 Eskisehir, Turkey
[2] Vet Affairs Med Ctr, Sch Med, GRECC, Dept Internal Med,Div Geriatr, St Louis, MO USA
[3] St Louis Univ, St Louis, MO 63103 USA
[4] Osmangazi Univ, Fac Med, Dept Physiol, Eskisehir, Turkey
关键词
vasoactive intestinal peptide; blood-brain barrier; high-performance liquid chromatography; unidirectional influx rate; cerebrospinal fluid; intracerebroventricular injection;
D O I
10.1016/S0196-9781(03)00059-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We investigated the ability of vasoactive intestinal peptide (VIP) to cross the blood-brain barrier (BBB), the interface between the peripheral circulation and central nervous system (CNS). VIP labeled with I-131 (I-VIP) and injected intravenously into mice was taken up by brain as determined by multiple-time regression analysis. Excess unlabeled VIP was unable to impede the entry of I-VIP, indicating that passage is by nonsaturable transmembrane diffusion. High pressure liquid chromatography (HPLC) showed the radioactivity entering the brain to be intact I-VIP. After intracerebroventricular (i.c.v.) injection, I-VIP was sequestered by brain, slowing its efflux from the CNS. In summary, VIP crosses the BBB unidirectionally from blood to brain by transmembrane diffusion. (C) 2003 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:437 / 444
页数:8
相关论文
共 50 条
  • [31] Microbubbles Deliver Across the Blood-Brain Barrier
    Ritter, Amy
    BIOPHARM INTERNATIONAL, 2011, 24 (11) : 10 - 10
  • [32] Charting the course across the blood-brain barrier
    Nathanson, David
    Mischel, Paul S.
    JOURNAL OF CLINICAL INVESTIGATION, 2011, 121 (01): : 31 - 33
  • [33] Drug delivery across the blood-brain barrier
    Hartz, AMS
    Bauer, B
    Baehr, CH
    Miller, DS
    Fricker, G
    CURRENT NANOSCIENCE, 2005, 1 (03) : 203 - 209
  • [34] Manganese Flux Across the Blood-Brain Barrier
    Yokel, Robert A.
    NEUROMOLECULAR MEDICINE, 2009, 11 (04) : 297 - 310
  • [35] Lipid transport across the blood-brain barrier
    Cecchelli, R
    ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY, 1996, 104 (04) : D126 - D127
  • [36] RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain
    Deane, R
    Yan, SD
    Submamaryan, RK
    LaRue, B
    Jovanovic, S
    Hogg, E
    Welch, D
    Manness, L
    Lin, C
    Yu, J
    Zhu, H
    Ghiso, J
    Frangione, B
    Stern, A
    Schmidt, AM
    Armstrong, DL
    Arnold, B
    Liliensiek, B
    Nawroth, P
    Hofman, F
    Kindy, M
    Stern, D
    Zlokovic, B
    NATURE MEDICINE, 2003, 9 (07) : 907 - 913
  • [37] SUGAR TRANSPORT ACROSS BLOOD-BRAIN BARRIER
    BUSCHIAZZO, PM
    TERRELL, EB
    REGEN, DM
    AMERICAN JOURNAL OF PHYSIOLOGY, 1970, 219 (05): : 1505 - +
  • [38] Polypeptide Delivery Across The Blood-Brain Barrier
    Pan, Weihong
    Kastin, Abba J.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2004, 3 (02) : 131 - 136
  • [39] RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain
    Rashid Deane
    Shi Du Yan
    Ram Kumar Submamaryan
    Barbara LaRue
    Suzana Jovanovic
    Elizabeth Hogg
    Deborah Welch
    Lawrence Manness
    Chang Lin
    Jin Yu
    Hong Zhu
    Jorge Ghiso
    Blas Frangione
    Alan Stern
    Ann Marie Schmidt
    Don L Armstrong
    Bernd Arnold
    Birgit Liliensiek
    Peter Nawroth
    Florence Hofman
    Mark Kindy
    David Stern
    Berislav Zlokovic
    Nature Medicine, 2003, 9 : 907 - 913
  • [40] RNAi delivered across the blood-brain barrier
    不详
    MOLECULAR THERAPY, 2004, 10 (01) : 3 - 3